22157.jpg
Global Cardiopulmonary Bypass Equipment Market to Reach USD 516.82 Million by 2028
16. Oktober 2023 05:28 ET | Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Cardiopulmonary Bypass Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ...
Global Cardiopulmonary Oxygenator Market
Global Cardiopulmonary Oxygenator Market Report 2023: Sector is Expected to Reach $904.15 Million by 2028 at a CAGR of 4%
26. Mai 2023 06:48 ET | Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Cardiopulmonary Oxygenator Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, Type, Age Group, and End Use" report...
MicrosoftTeams-image (5).png
Cardiovascular Proximal Anastomosis Devices Market to Surge at 5.7% CAGR, Reaching US$ 23.6 Million by 2030 - TMR Report
25. Mai 2023 09:30 ET | Transparency Market Research
Wilmington, Delaware, United States, May 25, 2023 (GLOBE NEWSWIRE) -- The global cardiovascular proximal anastomosis devices market is projected to flourish at a CAGR of 5.7% from 2020 to 2030. As...
FINAL-logo-tagline_RGB.png
Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting
08. Dezember 2017 09:00 ET | Asklepion Pharmaceuticals, LLC.
BALTIMORE, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of IV-citrulline for rare pediatric...